[marketocracy]
username: password: forgot? | sign up
[get quote]
research weekly insight
r e s e a r c h   r e p o r t s
 
[SAMPLE] Research Reports Week Ending Jan 07, 2011
sample only
 

Below is a sample of the data you will receive as a Premium Research subscriber.
You may view any Weekly Insight report older than 90 days.
To access more recent reports you must become a subscriber.

[ Join Up & Become a Premium Member Now ]

  
 
[get acrobat reader free]The research reports on this page are available in PDF, Adobe Acrobat, format. If you need Acrobat (it's free), click on the Acrobat icon.
 
 May 10, 2004  - Stock Alerts - 5/10/04
Commonwealth Biotechnologies, Inc. (CBTE) Recent Price $5.66
Profile: Commonwealth Biotechnologies, Inc. provides basic research services in the general areas of protein/peptide and DNA/RNA chemistries.

Best increased holdings by +34% Rest decreased holdings by -5%
As shares of Commonwealth Biotechnologies fell down from nearly $10 share in mid-April, the best began adding shares to their portfolio. At first, the top group added roughly 7% more shares of CBTE to the portfolio in the third week of April. However, in the recent 2 weeks, the best accelerated buying of CBTE by adding 34% to their position, bringing CBTE within the top 8% of total portfolio holdings. During the same recent two week period, the rest decreased their holdings of CBTE by -5%.

VaxGen Inc. (VXGN) Recent Price $14.72
Profile: VaxGen Inc. is a biopharmaceutical company focused on the commercial development and manufacture of products for the prevention and treatment of human infectious disease.

Best increased holdings by +176% Rest decreased holdings by -1%
The best increased their position by nearly 3 times its original size, raising their stake by 176% over the last 2 weeks. The hike in investment ranks VXGN in the top 13% of the portfolio, and comes just as VXGN's share price has fallen to under $15. Meanwhile, the rest sold down their position by -1%.

Royal Gold (RGLD) Recent Price $5.21
Profile: Royal Gold, Inc. is engaged in the acquisition and management of precious metals royalty interests. Royalty revenue is generated from mining operations in the United States and Argentina.

Best increased holdings by +16% Rest decreased holdings by -6%
Royal Gold's share price fell steeply during April, but the best held their position in the company unchanged through April 26th. Since that time, they've increased their holdings in the Gold miner by 16%, bringing the company to within the top 4% of total portfolio holdings. At the same time, the rest decreased their holdings in RGLD by -6%.

This week, we removed HNR, NAT, and VEIX from our Watchlist.
 
[click here to download report]  October 31, 2003  - November Marketscope
Click to download our latest Marketscope Newsletter, which includes our outlook for the market, asset allocation guidelines, and sector & stock analysis based on our m100 portfolio.
[ click here to download report ]
 
[click here to download report]  July 17, 2003  - m100 Fundspotlight: Carey Smith
Carey Smith has been one of the very best virtual managers at Marketocracy for quite some time. Over the last 2 1/2 years, he has compiled returns approaching +200%, all from his home in Como, Australia. The distance from Wall Street is helpful for him though, as he's able to filter out the "noise" and concentrate on stock picking.

We had the opportunity to interview Carey by phone, and discuss more about his path to investing success. And we've included the details of our conversation in this Fund Spotlight. Our Fund spotlight report is 3 pages long and details Carey's story, along with various fund statistics to give you a peak inside of his chart topping portfolio.

[ click here to download report ]
 
[click here to download report]  July 17, 2003  - m100 Fund Spotlight: Robert Clark
Robert Clark has been a consistent member of the m100, racking up gains over 145% in his portfolio over the last 2 1/2 years, and placing him among the elite investors at Marketocracy. He is a value investor whose fund concentrates on the Financials sector- the very same sector which the entire m100 weights most heavily in its portfolio.

Our Fund spotlight report is 5 pages long and contains an extensive interview with Robert, along with various fund statistics to give you a peak inside of his chart topping portfolio.
[ click here to download report ]